SCN9A and erythromelalgia: This study adds to the evidence for an essential role of NaV1.7 in the pain sensory pathway, and suggests that the extent of shift of voltage-dependence of activation of NaV1.7 may be a factor that is correlated with the rate of development of erythromelalgia symptoms.